Aptalis, is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The Company develops and markets a broad line of prescription products to treat cystic fibrosis and a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Aptalis’ products are marketed by its own specialized sales forces in North America and the European Union, and through commercial collaborations in many markets around the world.

© 2012 Aptalis. All rights reserved.

Site Map   |   Terms & Conditions   |   Privacy Policy   |   California Declaration   |   Aptalis Code of Conduct